These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7445918)

  • 1. [Impairment of the desmofibrinogenic activity of the fibrin stabilizing factor (FSF) due to free thiol group (SH) deficiency in middle-aged and old persons].
    Zuch A; Buluk K
    Acta Haematol Pol; 1980; 11(3):129-35. PubMed ID: 7445918
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of desmofibrinogenic activity and FSF (factor XIII of blood coagulation) level in plasma of healthy children in various age groups].
    Zuch A; Zwierzowa W; Rudobielska M; Buluk K
    Pediatr Pol; 1972 Oct; 47(10):1205-11. PubMed ID: 5085406
    [No Abstract]   [Full Text] [Related]  

  • 3. [Desmofibrinogenic activity of factor XIII and plasma concentration of thiol groups in the course of systemic scleroderma].
    Zuch A; Pietruska Z; Bogdanikowa B; Buluk K
    Reumatologia; 1979; 17(4):457-63. PubMed ID: 531372
    [No Abstract]   [Full Text] [Related]  

  • 4. Desmofibrin formation and the activity of the fibrin stabilizing factor (FSF) during the cleavage of its SH groups by thrombin.
    Buluk K; Olbromski J; Januszko T; Zuch A
    Thromb Diath Haemorrh; 1966 Jul; 16(1):51-60. PubMed ID: 5989050
    [No Abstract]   [Full Text] [Related]  

  • 5. [Desmofibrinogenic activity of factor XIII and thiol group levels of the plasma of patients with rheumatoid arthritis treated with levamisole].
    Zarzycka B; Pietruska Z; Górska M
    Pol Tyg Lek; 1983 Feb; 38(7):209-12. PubMed ID: 6866835
    [No Abstract]   [Full Text] [Related]  

  • 6. [Desmofibrinogenic activity and plasma thiol group concentration in systemic lupus erythematosus].
    Zuch A; Pietruska Z
    Wiad Lek; 1980 Apr; 33(8):601-5. PubMed ID: 7405222
    [No Abstract]   [Full Text] [Related]  

  • 7. [Desmofibrinogenesis impairment during neoplastic process].
    Zuch A; Buluk K
    Patol Pol; 1980; 31(3):351-6. PubMed ID: 7220115
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrin stabilization, factor XIII transamidase activity and subunits "A" and "B" concentration in plasma of patients with liver cirrhosis.
    Kłoczko J; Wereszczyńska U; Wojtukiewicz M; Gybryelewicz A; Bielawiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):539-44. PubMed ID: 2431976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of actual and potential fibrin-stabilizing factor (FSF) activity of blood plasma in healthy children.
    Zuch A; Buluk K; Rudobielska M; Zwierzowa W
    Z Kinderheilkd; 1972; 112(2):142-52. PubMed ID: 5023842
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activity of fibrin stabilizing factor (FSF; factor XIII) in lymphoproliferative disorders].
    Kłoczko J; Zuch A; Bielawiec M; Buluk K
    Acta Haematol Pol; 1983; 14(1):13-9. PubMed ID: 6577768
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of hormonal contraception on the fibrin-stabilizing factor (factor XIII)].
    Brandt M; Hofmann KD; Wagner F; Koob P
    Zentralbl Gynakol; 1978; 100(17):1089-92. PubMed ID: 716679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ontogenetic variability of fibrin stabilizing factor level (FSF--Factor XIII of blood coagulation system) in the plasma of healthy children].
    Zuch A; Rudobielska M; Zwierzowa W; Jurgielewicz E; Buluk K
    Pediatr Pol; 1972 Oct; 47(10):1197-203. PubMed ID: 5085405
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrin-stabilizing factor and its significance in the surgical treatment of patients with obstructive jaundice].
    Myslovatyĭ BS; Gorbovitskiĭ EB; Deputovich SA; Dzheĭranov FD
    Vestn Khir Im I I Grek; 1989 Mar; 142(3):79-81. PubMed ID: 2750013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physiological changes in concentrations of transaminase and free thiol groups in plasma of children].
    Zuch A; Buluk K; Rudobielska M; Czokalo M
    Pol Tyg Lek; 1974 Dec; 29(48):2061-3. PubMed ID: 4438158
    [No Abstract]   [Full Text] [Related]  

  • 15. [Physiological significance of the fibrin stabilizing factor (factor XIII)].
    Duckert F
    Schweiz Med Wochenschr; 1974 Sep; 104(39):1342-7. PubMed ID: 4424195
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of the thiol groups in the formation of desmofibrin.
    Buluk K; Zuch A
    Pol Med J; 1971; 10(4):886-94. PubMed ID: 5126382
    [No Abstract]   [Full Text] [Related]  

  • 17. [Impairment of desmofibrinogenic activity of blood as a cause of tissue regeneration disorder].
    Kłoczko J; Zuch A; Bielawiec M
    Wiad Lek; 1980 Feb; 33(4):287-90. PubMed ID: 6967238
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of fibrin stabilizing factor (FSF) deficiency].
    Amris CJ; Ranek L
    Ugeskr Laeger; 1965 Dec; 127(52):1673-8. PubMed ID: 5868675
    [No Abstract]   [Full Text] [Related]  

  • 19. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SH--SS transition reactions during fibrin formation].
    Mironov GP; Molchanova LV
    Vopr Med Khim; 1971; 17(3):301-6. PubMed ID: 5107335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.